Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Biomarkers and the genetics of early neoplastic lesions.

Srivastava S, Grizzle WE.

Cancer Biomark. 2010;9(1-6):41-64. doi: 10.3233/CBM-2011-0204. Review.

2.

Post-transcriptional processing of genetic information and its relation to cancer.

McNally L, Manne U, Grizzle WE.

Biotech Histochem. 2013 Oct;88(7):365-72. doi: 10.3109/10520295.2012.730152. Epub 2013 Jan 4.

3.

Epigenetic biomarkers.

Chan TA, Baylin SB.

Curr Top Microbiol Immunol. 2012;355:189-216. doi: 10.1007/82_2011_165.

PMID:
21818705
4.

Translational pathology of neoplasia.

Grizzle WE, Srivastava S, Manne U.

Cancer Biomark. 2010;9(1-6):7-20. doi: 10.3233/CBM-2011-0159.

5.
6.

Understanding the cancer cell phenotype beyond the limitations of current omics analyses.

Moreno-Sánchez R, Saavedra E, Gallardo-Pérez JC, Rumjanek FD, Rodríguez-Enríquez S.

FEBS J. 2016 Jan;283(1):54-73. doi: 10.1111/febs.13535. Epub 2015 Oct 27. Review.

7.

Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.

Jeevan DS, Cooper JB, Braun A, Murali R, Jhanwar-Uniyal M.

Anticancer Res. 2016 Feb;36(2):523-32.

PMID:
26851006
8.

Potential markers of tongue tumor progression selected by cDNA microarray.

Carinci F, Lo Muzio L, Piattelli A, Rubini C, Chiesa F, Ionna F, Palmieri A, Maiorano E, Pastore A, Laino G, Dolci M, Pezzetti F.

Int J Immunopathol Pharmacol. 2005 Jul-Sep;18(3):513-24.

PMID:
16164832
9.

Molecular mechanisms of microRNAs in regulating epithelial-mesenchymal transitions in human cancers.

Tang J, Li Y, Wang J, Wen Z, Lai M, Zhang H.

Cancer Lett. 2016 Feb 28;371(2):301-13. doi: 10.1016/j.canlet.2015.11.043. Epub 2015 Dec 9. Review.

PMID:
26683775
10.

NF90 in posttranscriptional gene regulation and microRNA biogenesis.

Masuda K, Kuwano Y, Nishida K, Rokutan K, Imoto I.

Int J Mol Sci. 2013 Aug 19;14(8):17111-21. doi: 10.3390/ijms140817111. Review.

11.

MicroRNAs: molecular features and role in cancer.

Lages E, Ipas H, Guttin A, Nesr H, Berger F, Issartel JP.

Front Biosci (Landmark Ed). 2012 Jun 1;17:2508-40. Review.

12.

miRNA control of tumor cell invasion and metastasis.

Baranwal S, Alahari SK.

Int J Cancer. 2010 Mar 15;126(6):1283-90. doi: 10.1002/ijc.25014. Review.

13.

New cancer biomarkers deriving from NCI early detection research.

Verma M, Srivastava S.

Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.

PMID:
12903844
14.
15.

Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy.

Tarin D, Matsumura Y.

J Cell Biochem Suppl. 1993;17G:173-85. Review.

PMID:
7516458
16.

Common gene polymorphisms, cancer progression and prognosis.

Loktionov A.

Cancer Lett. 2004 May 10;208(1):1-33. Review.

PMID:
15105042
17.

The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.

Balch C, Nephew KP.

Cancer Biomark. 2010-2011;8(4-5):203-21. doi: 10.3233/CBM-2011-0214.

PMID:
22045354
18.

The role of periostin in neoplastic processes.

Ratajczak-Wielgomas K, Dziegiel P.

Folia Histochem Cytobiol. 2015;53(2):120-32. doi: 10.5603/FHC.a2015.0014. Epub 2015 Jul 7. Review.

19.

miRNA and cancer; computational and experimental approaches.

Tutar Y.

Curr Pharm Biotechnol. 2014;15(5):429.

PMID:
25189575
20.

Post-transcriptional regulation in cancer.

Audic Y, Hartley RS.

Biol Cell. 2004 Sep;96(7):479-98. Review.

PMID:
15380615

Supplemental Content

Support Center